Article Versions Notes

Wang Z, Guo Z, Wang X, Liao H, Chai Y, Wang Z, Wang Z. Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway. Cells. 2022; 11(24):3958. https://doi.org/10.3390/cells11243958

Wang, Ziyi, Zhe Guo, Xuesong Wang, Haiyan Liao, Yan Chai, Ziwen Wang, and Zhong Wang. 2022. "Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway" Cells 11, no. 24: 3958. https://doi.org/10.3390/cells11243958

Wang, Z., Guo, Z., Wang, X., Liao, H., Chai, Y., Wang, Z., & Wang, Z. (2022). Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway. Cells, 11(24), 3958. https://doi.org/10.3390/cells11243958